148 related articles for article (PubMed ID: 32692618)
1. Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries.
Yashkin AP; Greenup RA; Gorbunova G; Akushevich I; Oeffinger KC; Hwang ES
JCO Oncol Pract; 2021 Apr; 17(4):e469-e478. PubMed ID: 32692618
[TBL] [Abstract][Full Text] [Related]
2. Projections of the cost of cancer care in the United States: 2010-2020.
Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
4. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
5. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer.
Sloan FA; Yashkin AP; Akushevich I; Inman BA
Urol Oncol; 2020 Feb; 38(2):39.e11-39.e19. PubMed ID: 31761612
[TBL] [Abstract][Full Text] [Related]
7. Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis.
Grady I; Grady S; Chanisheva N
Eur J Health Econ; 2021 Dec; 22(9):1365-1370. PubMed ID: 34008086
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
9. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
10. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
11. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
12. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
13. Annual health care costs among Medicare Beneficiaries with essential tremor.
Kapinos KA; Louis ED
Parkinsonism Relat Disord; 2022 Nov; 104():26-29. PubMed ID: 36206644
[TBL] [Abstract][Full Text] [Related]
14. Costs of breast cancer recurrence after initial treatment for HR+, HER2-, high-risk early breast cancer: estimates from SEER-Medicare linked data.
Vitko AS; Martin P; Zhang S; Johnston A; Ohsfeldt R; Zheng S; Liepa AM
J Med Econ; 2024; 27(1):84-96. PubMed ID: 38059275
[TBL] [Abstract][Full Text] [Related]
15. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
Mukherjee K; Small W; Duszak R
Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
[TBL] [Abstract][Full Text] [Related]
16. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
17. Resource Use and Medicare Costs During Lay Navigation for Geriatric Patients With Cancer.
Rocque GB; Pisu M; Jackson BE; Kvale EA; Demark-Wahnefried W; Martin MY; Meneses K; Li Y; Taylor RA; Acemgil A; Williams CP; Lisovicz N; Fouad M; Kenzik KM; Partridge EE;
JAMA Oncol; 2017 Jun; 3(6):817-825. PubMed ID: 28125760
[TBL] [Abstract][Full Text] [Related]
18. Cost of cancer management by stage at diagnosis among Medicare beneficiaries.
Reddy SR; Broder MS; Chang E; Paydar C; Chung KC; Kansal AR
Curr Med Res Opin; 2022 Aug; 38(8):1285-1294. PubMed ID: 35285354
[TBL] [Abstract][Full Text] [Related]
19. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
Riley GF; Potosky AL; Lubitz JD; Kessler LG
Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
[TBL] [Abstract][Full Text] [Related]
20. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
